• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is no longer a death sentence. With the available treatments, an HIV-positive person lives almost as long as someone who is not infected with the virus, on the condition that you daily take virus inhibitors. However, this increases the number of HIV positive people from year to year, which also increases the annual necessary budget for HIV treatment.

MDx Health gains market access of the Middle East via partner IPS Genomix.

Singapore's Agency for Science, Technology and Research will develop the new assay while Biocartis will be responsible for commercialisation.

Aphea.Bio focusses on plant-bacterial interactions for the development of biopesticides and biostimulants based on naturally occurring microorganisms.

Methylation specialist MDx Health brings its third assay to the market. The AssureMDx liquid biopsy assay is able to detect bladder cancer in a urine sample.

The anti-inflammatory molecule enters yet another phase II trial.

Under the guidance of Flam3D, the Flemish cluster association for 3D printing, 27 Flemish companies and research institutions collaborate on the realization of 'Family of the Future'. This will be a demonstration project aimed at clarifying what 3D printing technologies exist and how they can have real added value across a wide range of sectors.

The Belgian developer of the DropSense system Trinean is being acquired by American lab devices developer Unchained Labs.

  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is no longer a death sentence. With the available treatments, an HIV-positive person lives almost as long as someone who is not infected with the virus, on the condition that you daily take virus inhibitors. However, this increases the number of HIV positive people from year to year, which also increases the annual necessary budget for HIV treatment.

MDx Health gains market access of the Middle East via partner IPS Genomix.

Singapore's Agency for Science, Technology and Research will develop the new assay while Biocartis will be responsible for commercialisation.

Aphea.Bio focusses on plant-bacterial interactions for the development of biopesticides and biostimulants based on naturally occurring microorganisms.

Methylation specialist MDx Health brings its third assay to the market. The AssureMDx liquid biopsy assay is able to detect bladder cancer in a urine sample.

The anti-inflammatory molecule enters yet another phase II trial.

Under the guidance of Flam3D, the Flemish cluster association for 3D printing, 27 Flemish companies and research institutions collaborate on the realization of 'Family of the Future'. This will be a demonstration project aimed at clarifying what 3D printing technologies exist and how they can have real added value across a wide range of sectors.

The Belgian developer of the DropSense system Trinean is being acquired by American lab devices developer Unchained Labs.